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Abstract Low-level laser (light) therapy (LLLT) has been
applied recently to body contouring. However the mechanism
of LLLT-induced reduction of subcutaneous adipose tissue
thickness has not been elucidated and proposed hypotheses
are highly controversial. Non-obese volunteers were subject
to 650nm LLLT therapy. Each patient received 6 treatments 2-
3 days apart to one side of the abdomen. The contralateral side
was left untreated and served as control. Subjects’ abdominal
adipose tissue thickness was measured by ultrasound imaging
at baseline and 2 weeks post-treatment. Our study is to the best
of our knowledge, the largest split-abdomen study employing
subcutaneous abdominal fat imaging. We could not show a
statistically significant reduction of abdominal subcutaneous
adipose tissue by LLLT therapy. Paradoxically when the mea-
surements of the loss of fat thickness on treated side was
corrected for change in thickness on non treated side, we have
observed that in 8 out of 17 patients LLLT increased adipose
tissue thickness. In two patients severe side effect occurred as
a result of treatment: one patient developed ulceration within
appendectomy scar, the other over the posterior superior iliac
spine. The paradoxical net increase in subcutaneous fat thick-
ness observed in some of our patients is a rationale against
liquefactive and transitory pore models of LLLT-induced
adipose tissue reduction. LLLT devices with laser diode
panels applied directly on the skin are not as safe as devices
with treatment panels separated from the patient’s skin.
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Introduction
Low-level laser therapy (LLLT) is defined as an application of
low-irradiancy laser light (1 mW–5W/cm2) where therapeutic
results are achieved without photothermal nor photoacoustic
effects. LLLT is widely used as a therapeutic modality to pro-
mote wound healing and reduce pain, tissue inflammation,
and damage [1–4]. More recently, there have been attempts
to apply LLLT to treat acne, scars, alopecia, and cellulite.
LLLT devices are also marketed for cosmetic use in body
contouring and reduction of subcutaneous fat thickness
[5–11]. Despite several studies reported a significant reduction
of subcutaneous fat thickness induced by LLLT, the exact
mechanism by which LLLT acts on fatty tissue has not been
elucidated. An original explanation to the phenomenon of fat
tissue interaction with laser light, provided by Neira et al., was
that laser irradiation permeabilizes cell membranes inducing
pores in cell membrane, what results in the passive spillage of
lipids into the interstitial space [11]. Alternative hypothesis is
that LLLTaffects lipid metabolism in adipocytes and/or trans-
port of lipids through cell membrane without affecting its
integrity [9].
The aim of this study was to investigate the efficacy and
safety of LLLT in reduction of subcutaneous adipose tissue
thickness and to verify whether the mode of action on adipose
tissue depends on local or systemic mechanisms.
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Methods and procedures
Twenty-four healthy men and women, aged 22 to 55 years
with bodymass indexes (BMI) below 30 kg/m2, were enrolled
in the study. The exclusion criteria were obesity, previous
liposuction or abdominoplasty, and pregnancy. Subjects
agreed to refrain from participating in any other body
contouring or weight loss procedures or programs during the
course of the study including, but not limited to, over-the-
counter and prescription appetite suppressants, diet plans, sur-
gical procedures, and alternative therapies. The study was
conducted with the principles of the Declaration of Helsinki
and was approved by the ethics committee on research at the
Nicolaus Copernicus University.
The subjects’ waist circumference and body weight
were measured and photographs were obtained before ev-
ery treatment. The subjects underwent ultrasound imaging
at baseline and 2 weeks post-treatment. Subcutaneous ad-
ipose tissue thickness was measured in three points over
the left and right rectus abdominis muscle from the
dermis-fat interface down to the deep fat-muscle fascia
interface.
Each subject received six treatments 2 to 3 days apart with
the LLLT device (Lipo Laser, Mimari, Poland) over a 2-week
period. The device is composed of six panels measuring 8 by
16 cm each. The 100-mW laser diodes of 650 nm wavelength
are distributed in the panel every 4 cm, totaling 8 emitters per
panel and 48 emitters in total. The total skin area covered by
laser panels was 768 cm2, and the surface power density was
9.14 mW/cm2. Laser panels were applied directly on the skin
for 20min. Elevated rim of the panel provided 0.5 cm distance
of laser diodes from the skin surface. The total laser energy
that patients were exposed to during one session was 7.5 J/
cm2. Only the right side of the abdomenwas irradiated; the left
side was untreated and served as control.
Clinical assessment of any side effects such as erythema,
edema, blistering, hyperpigmentation, hypopigmentation,
whitening, purpura, ulceration, and scarring were done before
each treatment session and at the follow-up visit 2 weeks after
the last treatment.
Statistical analysis was performed using STATISTICAver-
sion 12.0 software. Data normality was verified with the
Shapiro-Wilk test. Parametric data were expressed as mean
± SD. To analyze the effects of intervention, delta values (Δ)
were used obtained from the difference between the post-
treatment and baseline values for each variable: Δ variable =
post treatment value − baseline value. Comparing the delta
values between the groups was performed by t test for inde-
pendent samples, t test for dependent samples, and ANOVA
for repeated measurements. The net treatment benefit
(change) was calculated as a difference between change of
fat thickness on treated side and change of thickness on con-
trol side (net benefit = (Σ treated side pre-treatment − Σ treat-
ed side post treatment) − (Σ control side pre-treatment − Σ
control side post treatment)).
Results
Nineteen subjects completed the study (but two were not
available for post-treatment ultrasound evaluation). The rea-
sons for discontinuation of participation in the study was self-
assessed lack of benefit (n = 3) and side effects (n = 2).
Erythema lasting more than 24 h after the treatment was re-
ported in four patients, and two of those patients developed
ulcerations in irradiated area. One patient developed ulcera-
tion within the appendectomy scar, the other over the posterior
superior iliac spine (Fig 1).
The results of anthropometric measurements of the studied
population at baseline are summarized in Table 1. Post-
Fig. 1 One patient developed
ulceration within appendectomy
scar, the other over the posterior
superior iliac spine
476 Lasers Med Sci (2017) 32:475–479
treatment results are illustrated as chart of individual changes
in abdominal fat tissue thickness in Fig 2 and as descriptive
statistics of ultrasound measurements of abdominal adipose
tissue thickness in Table 2. Although a trend towards reduc-
tion of adipose tissue thickness was observed, the results are
statistically not significant (p = 0.47). The maximal combined
reduction of adipose tissue of 16.3 mm was achieved in pa-
tient 15. We have observed a correlation between the weight
loss and the reduction of fat thickness on treated (p = 0.068)
and non-treated (p = 0.065) side. Paradoxically, when the
measurements of the loss of fat thickness on the treated side
was corrected for change in thickness on the non-treated side,
we have observed that in 8 out of 17 patients, LLLT increased
adipose tissue thickness. In patient 11, the combined increase
of adipose tissue thickness totaled to 8.8 mm. No correlation
was found between the reduction of adipose tissue thickness
and patient’s age, initial weight, initial BMI, initial waist cir-
cumference nor sex.
Discussion
Compared to previously published studies [7], we have noted
a relatively large number of side effects (4 out of 24 patients
vs. 0 out of 86). There is an important technical difference
between the LLLT device used in our study (Lipolaser,
Mimari, Poland) and that of McRae et al.’s (Zerona,
Erchonia, USA) that the device used by us has laser-diode
panels attached directly to the patient’s skin, whereas one used
by McRae et al. has laser diodes operating 15 cm from the
patient’s skin. Despite LLLT acting in a non-thermal manner,
the waste heat generated by laser diodes may compromise
premise of LLLT and cause injury to the patient’s skin if in
close contact.
Table 1 Anthropometric measurements of the studied population at
baseline
Variable X ± S V As Ku-3
Age 37.24 ± 13.30 35.72 0.01 −1.91
Body mass (kg) 68.97 ± 13.67 19.82 0.95 1.51
Body mass index (kg/m2) 23.60 ± 2.89 12.25 0.36 −0.02
Σ left side of abdomen (cm) 7.24 ± 2.80 38.61 −0.67 −0.24
Σ right side of abdomen (cm) 7.15 ± 2.66 37.28 −0.51 −0.14
X arithmetic average, S standard deviation, V coefficient of variation, As
coefficient asymmetry, Ku-3 coefficient of kurtosis
Fig. 2 Post-treatment results of individual changes in abdominal fat tissue thickness
Table 2 Descriptive statistics of ultrasound measurements of
abdominal adipose tissue thickness
Side X ± S
[cm]
V As Ku-3
Weight loss (kg) 1.25 ± 1.03 83.59 −0.15 0.38
Waist circumference
loss (cm)




Left 7.24 ± 2.80 38.61 −0.67 −0.24




Left (control) 7.40 ± 2.70 36.47 −0.64 −0.21
Right (treated) 7.08 ± 2.45 34.61 −0.32 −0.25
Thickness presented as a sum of three measurements over the rectus
abdominis muscle from the dermis-fat interface down to the deep fat-
muscle fascia interface. X arithmetic average, S standard deviation, V
coefficient of variation, As coefficient asymmetry, Ku-3 coefficient of
kurtosis
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Efficacy of LLLT in reduction of thickness of subcutaneous
fat has previously been confirmed by studies involving much
larger populations; therefore, one can argue that its failure to
show in our study results from insufficient sample. Lack of
significance of adipose tissue thickness reduction in our study
as compared with strong evidence of efficacy in Jackson’s
study (p < 0.0001) could be explained by methodological dif-
ferences, particularly in a much smaller area treated in our
study [12].
However, treatment protocols in majority of studies per-
formed to date combined LLLT treatments with, often several
months long, intensive aerobic plus resistance training
[13–15] or required subjects to utilize a weight loss supple-
ment [7, 16]. Majority of studies designed to verify effects of
LLLT alone used circumference measurements as the only
estimator of subcutaneous fat layer thickness [8, 9, 12]
Estimation of the adipose tissue thickness, especially in the
abdominal area based solely on circumference measurements,
may be confounded by dietary factors, medical conditions,
and medications that cause bloating or swelling. The con-
founding factors could be removed by the split-abdomen
study design and use of objective methods of adipose tissue
thickness assessment such as ultrasound or NMR imaging.
The only split-abdomen study with ultrasound imaging eval-
uation of subcutaneous fat layer thickness by Elm et al. [16]
enrolled only two patients for LLLT-only arm of the study.
Our study is, to the best of our knowledge, the largest split-
abdomen study employing subcutaneous abdominal fat
imaging.
Our result is clearly discordant with those obtained in a
well-designed randomized double-blinded study by Jackson
et al. [12] and another large-scale study [10], yet they may be
mechanistically reconciled.
Two models of LLLT action on subcutaneous adipose tis-
sue have been proposed in the past. Neira et al. suggested that
LLLT disrupts adipocyte cell membranes and allows the lipids
to Bspill^ from the cell [11]. Assuming the liquefactive mode
of action of LLLT, one expects prominent local effects with
little or no effect in non-treated areas. We have found that in
some of our patients, there was a net increase in subcutaneous
fat thickness which cannot be reconciled with liquefactive
model.
Alternative hypothesis is that LLLT induces triglyceride
mobilization from unharmed cells. Caruso-Davis et al.
showed increased triglyceride content in supernatants of
LLLT-treated primary adipocytes while the cells themselves
showed decreased calcein staining post-treatment compared to
non-treated cells [9]. The viability of treated and non-treated
cells, as determined by the propidium iodide assay, was sim-
ilar; hence, Caruso-Davis et al. suggested that this proves for-
mation of transitory pores in the cell membrane. However, in
our opinion, upregulation of multidrug resistance protein 1,
responsible for calcein extrusion from the cells, would present
with the same results. Again, the net increase in subcutaneous
fat thickness observed by us in some of our patients is difficult
to be reconciled with transitory pore model.
In a study by Jackson et al. [12], significant circum-
ferential reduction in non-treated areas was reported
what could suggest that LLLT affects systemic lipid me-
tabolism, possibly involving an intermediate acting in an
autocrine/paracrine manner. Animal studies seem to sup-
port this hypothesis and further corroborate our results.
Aquino et al. showed that LLLT significantly decreased
relative mass of fat tissue in trained animals while it
tended to increase body weight and fat content in sed-
entary animals [17]. The paradoxical positive effect of
LLLT in some of our patients and negative in others
could result from differences in the patients’ physical
exercise routines; unfortunately, our study did not measure
this variable.
A large body of evidence suggests that vascular ox-
idative stress induces obesity and metabolic syndrome
[18] while oxidative stress in adipose tissue not only
correlates with insulin resistance but is also causative
in its development [19]. Moreover, oxidative stress in
adipose tissue decreases adiponectin secretion [20]
resulting in a decrease of adiponectin-induced energy
expenditure associated with protein uncoupling [21].
LLLT has been shown to reduce oxidative stress in
neural and muscular tissue [3, 22]; however, as to our
knowledge, the effects of LLLT on adipocyte oxidative
stress levels have not been studied. Further studies are
necessary to elucidate this problem. It is tempting to
speculate that LLLT-induced reduction of adipose tissue
thickness results from decreased oxidative stress in adi-
pocytes and consequently increased adiponectin secre-
tion and decreased insulin resistance. Under this model,
the combination of LLLT and aerobic exercise is crucial
for its efficacy in the reduction of subcutaneous adipose
tissue thickness.
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